Effect of intranasal triamcinolone acetonide on basal hypothalamic- pituitary-adrenal axis function in children with allergic rhinitis

Allergy and Asthma Proceedings

Volumn 35, Issue 2, 2014, Pages 163-170

  Georges, George ^a   Kim, Kenneth T ^b   Ratner, Paul ^c   Segall, Nathan ^d   Qiu, Chunfu ^e  

^a GLAXOSMITHKLINE   (United States)

^b WCCT Global   (United States)

^c Southwest Allergy and Asthma Center   (United States)

^d Clinical Research Atlanta   (United States)

^e SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; NOSE SPRAY; PLACEBO; TRIAMCINOLONE ACETONIDE; ANTIINFLAMMATORY AGENT;

AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY TEMPERATURE; BODY WEIGHT; BREATHING RATE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; HAY FEVER; HEART RATE; HUMAN; HUMERUS FRACTURE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MORNING DOSAGE; MULTICENTER STUDY; PARALLEL DESIGN; PERENNIAL RHINITIS; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VOMITING; CLINICAL TRIAL; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRANASAL DRUG ADMINISTRATION; RHINITIS, ALLERGIC; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RHINITIS, ALLERGIC; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 84897088436     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2014.35.3728     Document Type: Article

References (31)

1. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122(suppl 2):S1-S84, 2008. (Pubitemid 352033573)
2. Sanofi-Aventis U.S., LLC. Nasacort AQ package insert. Bridgewater, NJ; November 2010.
3. Schenkel EJ, Gross G, Jacobson K, et al. Triamcinolone acetonide aqueous nasal inhaler for the treatment of spring grass seasonal allergic rhinitis in children. Pediatr Asthma Allergy Immunol 11:129-136, 1997. (DOI: 10.1089/pai.1997.11.129)
4. Weinstein S, Qaqundah P, Georges G, and Nayak A. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: A randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol 102:339-347, 2009.
5. Berger WE, Kaiser H, Gawchik SM, et al. Triamcinolone acetonide aqueous nasal spray and fluticasone propionate are equally effective for relief of nasal symptoms in patients with seasonal allergic rhinitis. Otolaryngol Head Neck Surg 129:16-23, 2003. (Pubitemid 37391039)
6. Munk ZM, LaForce C, Furst JA, et al. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 77:277-281, 1996. (Pubitemid 27014582)
7. Gross G, Jacobs RL, Woodworth TH, et al. Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis. Ann Allergy Asthma Immunol 89:56-62, 2002. (Pubitemid 36188068)
8. Kaiser HB, Liao Y, Diener P, et al. Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity. Allergy Asthma Proc 25:423-428, 2004. (Pubitemid 40221590)
9. Chrousos GP, and Harris AG. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles. Neuroimmunomodulation 5:277-287, 1998. (Pubitemid 28484982)
10. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 105:E23, 2000.
11. Perry RJ, Findlay CA, and Donaldson MD. Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child 87:45-48, 2002. (Pubitemid 34753773)
12. Bruni FM, De Luca G, Venturoli V, and Boner AL. Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation 16:353-362, 2009.
13. Chalew SA, Zadik Z, McCarter R, and Kowarski AA. Hypocortisolemia in children undergoing evaluation for growth hormone deficiency. J Clin Endocrinol Metab 71:952-957, 1990.
14. Jennings BH, Andersson KE, and Johansson SA. Assessment of the systemic effects of inhaled glucocorticosteroids: The influence of blood sampling technique and frequency on plasma cortisol and leucocytes. Eur J Clin Pharmacol 39:127-131, 1990. (Pubitemid 20249984)
15. Law CM, Marchant JL, Honour JW, et al. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet 1:942-944, 1986. (Pubitemid 16143074)
16. Phillip M, Aviram M, Leiberman E, et al. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol 12:84-89, 1992.
17. Howland WC III, Dockhorn R, Gillman S, et al. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J Allergy Clin Immunol 98:32-38, 1996. (Pubitemid 26289383)
18. Nayak AS, Ellis MH, Gross GN, et al. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis. J Allergy Clin Immunol 101:157-162, 1998. (Pubitemid 28152376)
19. Skoner DP, Gentile D, Angelini B, et al. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol 90:56-62, 2003. (Pubitemid 36553817)
20. Eid N, Morton R, Olds B, et al. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics 109:217-221, 2002. (Pubitemid 34126860)
21. Patel D, Ratner P, Clements D, et al. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. Ann Allergy Asthma Immunol 100:490-496, 2008. (Pubitemid 351668787)
22. Marshall WA, and Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303, 1969.
23. Marshall WA, and Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23, 1970.
24. Food and Drug Administration (FDA). Draft Guidance for Industry - Bioavailability and bioequivalence studies for nasal sprays for local action. U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Rockville, MD. 2003. Available online at www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/ucm070111.pdf; accessed November 26, 2013.
25. Blaiss MS. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 32:413-418, 2011.
26. Banov CH, Silvers WS, Green AW, et al. Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clin Ther 18:265-272, 1996. (Pubitemid 26167436)
27. Howland WC 3rd, Dockhorn R, Gillman S, et al. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J Allergy Clin Immunol 98:32-38, 1996. (Pubitemid 26289383)
28. Tripathy I, Levy A, Ratner P, et al. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis. Pediatr Allergy Immunol 20:287-294, 2009.
29. Allen DB. Systemic effects of intranasal steroids: An endocrinologist's perspective. J Allergy Clin Immunol 106(suppl):S179-S190, 2000.
30. Zadik Z, De Lacerda L, De Carmargo LA, et al. A comparative study of urinary 17-hydroxycorticosteroids, urinary free cortisol, and the integrated concentration of plasma cortisol. J Clin Endocrinol Metab 51:1099-1101, 1980. (Pubitemid 11225469)
31. Becker AB, Kuznetsova O, Vermeulen J, et al. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week randomized double-blind study. Ann Allergy Asthma Immunol 96:800-807, 2006.